SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-14-000021
Filing Date
2014-01-07
Accepted
2014-01-07 15:50:10
Documents
4
Period of Report
2014-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e611728_8k-retrophin.htm 8-K 28489
2 e611728_ex3-1.htm EX-3.1 100553
3 e611728_ex10-1.htm EX-10.1 19021
4 e611728_ex10-2.htm EX-10.2 16365
  Complete submission text file 0001193805-14-000021.txt   165710
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 8-K | Act: 34 | File No.: 000-53293 | Film No.: 14513421
SIC: 2834 Pharmaceutical Preparations